Agentix (AGTX) Other Operating Expenses (2013 - 2026)
Agentix's (AGTX) quarterly Other Operating Expenses came in at $37500.0 in Q1 2026, down 41.79% YoY from $64424.0 in Q1 2025, and down 26.0% on a QoQ basis from $50678.0 in Q4 2025.
Agentix (AGTX) Other Operating Expenses (2013 - 2026) Analysis & Trends
Agentix (AGTX) has 14 years of Other Operating Expenses data on file, last reported at $37500.0 in Q1 2026.
- Quarterly Other Operating Expenses fell 41.79% year-over-year to $37500.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $252036.0 (down 3.94% YoY) and the FY2026 annual result came in at $252036.0, down 3.94% from the prior year.
- Other Operating Expenses fell to $37500.0 in Q1 2026, from $50678.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $1.9 million in Q1 2022 to a low of -$92348.0 in Q1 2024.
- A 5-year average of $183616.8 and a median of $78040.0 in 2023 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2022 — Other Operating Expenses jumped 264.1% — and 2024, when it sank 141.31%.
- Tracing AGTX's Other Operating Expenses over 5 years: stood at $139821.0 in 2022, then plunged by 44.19% to $78040.0 in 2023, then slipped by 27.43% to $56632.0 in 2024, then decreased by 10.51% to $50678.0 in 2025, then declined by 26.0% to $37500.0 in 2026.
- The last three Other Operating Expenses figures came in at $37500.0 (Q1 2026), $50678.0 (Q4 2025), and $81233.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Agentix | 801,339.00 | 801,301.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62,084.00 |
| Mar 31, 2026 | 37,500.00 |
| Dec 31, 2025 | 50,678.00 |
| Sep 30, 2025 | 81,233.00 |
| Jun 30, 2025 | 82,625.00 |
| Mar 31, 2025 | 64,424.00 |
| Dec 31, 2024 | 56,632.00 |
| Sep 30, 2024 | 64,310.00 |
| Jun 30, 2024 | 77,000.00 |
| Mar 31, 2024 | -92,348.00 |
| Dec 31, 2023 | 78,040.00 |
| Sep 30, 2023 | 122,181.00 |
| Jun 30, 2023 | 115,126.00 |
| Mar 31, 2023 | 223,565.00 |
| Dec 31, 2022 | 139,821.00 |
| Sep 30, 2022 | 68,008.00 |
| Jun 30, 2022 | 88,844.00 |
| Feb 28, 2022 | 1.86 Mn |
| Nov 30, 2021 | 108,465.00 |
| Aug 31, 2021 | 114,883.00 |